Developing a quality management system for the European Network for Health Technology Assessment (EUnetHTA): toward European HTA collaboration

27 April 2021 - The European Network for Health Technology Assessment (EUnetHTA) was established in 2006 and comprises over eighty organisations ...

Read more →

Patient and public involvement in health technology assessment: a new dawn?

12 April 2021 - Patient and public involvement and engagement have become increasingly embedded in health technology assessment over the last ...

Read more →

Development of an international template to support patient submissions in health technology assessments

1 April 2021 - The objective was to develop an international template to support patient submissions in health technology assessments.  ...

Read more →

MHRA pilot seeks evidence of patient involvement in R&D

25 March 2021 - The UK MHRA has begun a pilot project to encourage patient involvement in drug development, asking ...

Read more →

TGA adopts Access Consortium guidance for fast-tracking authorisations of modified COVID-19 vaccines for variant

5 March 2021 - TGA has adopted guidance developed by the Access Consortium - a coalition of regulatory authorities from ...

Read more →

Modified COVID-19 vaccines for variants to be fast-tracked, says MHRA and other regulators

4 March 2021 - Future vaccine modifications that respond to new variants of coronavirus to be made available quickly to UK recipients, without compromising on safety, ...

Read more →

International cooperation to align approaches for regulation of COVID-19 vaccines and medicines

25 February 2021 - Regulators around the globe are committed to aligning their regulatory requirements and addressing knowledge gaps to facilitate ...

Read more →

EMA plots earlier engagement with patient groups

19 February 2021 - The EMA on Friday announced it will pilot an early engagement program to bring patient and ...

Read more →

Collaboration between the FDA and industry is essential to foster innovation in Alzheimer’s treatments

8 February 2021 - As the Food and Drug Administration moves closer to a decision about whether to approve a ...

Read more →

International regulators working together to enhance collaboration on COVID-19 observational research

8 February 2021 - In a dedicated COVID-19 workshop, convened under the umbrella of the International Coalition of Medicines Regulatory Authorities, ...

Read more →

TGA one of only five non-European regulators invited to participate on European committees on COVID-19 vaccines and therapeutics

8 February 2021 - Australia, through the TGA, is one of only five non-European Union regulators formally invited to participate ...

Read more →

Patient and public involvement in health technology assessment: update of a systematic review of international experiences

5 February 2021 - This paper summarises the current evidence on patient and public involvement in health technology assessment  in order ...

Read more →

Evaluation of the impact of patient input in health technology assessments at NICE

29 January 2021 - Accounts of patient experiences are increasingly used in health technology assessment processes. However, we know little about ...

Read more →

Creating a patient and community advisory committee at the Canadian Agency for Drugs and Technologies in Health

22 January 2021 - In recognition of patients’ roles using, and contributing to, a publicly funded health system, the Canadian Agency ...

Read more →

Patient involvement in relative effectiveness assessments in the European Network for Health Technology Assessment

20 January 2021 - Patient involvement in the process of producing health technology assessments has become increasingly important. In the ...

Read more →